(4-traders.com) J. Goldman & Company lowered its stake in shares of SPDR S&P Biotech by 20.8% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The hedge fund owned 196,000 shares of the companys stock after selling 51,500 shares during the period. SPDR S&P Biotech accounts for about 1.0%...http://www.4-traders.com/EMM-16118018/news/EMM--J-Goldman--Company-Sells-12201000-in-SPDR-SP-Biotech-XBI-Shares-21583859/